Cargando…
A randomized controlled trial to determine whether beta-hydroxy-beta-methylbutyrate and/or eicosapentaenoic acid improves diaphragm and quadriceps strength in critically Ill mechanically ventilated patients
BACKGROUND: Intensive care unit acquired weakness is a serious problem, contributing to respiratory failure and reductions in ambulation. Currently, there is no pharmacological therapy for this condition. Studies indicate, however, that both beta-hydroxy-beta-methylbutyrate (HMB) and eicosapentaenoi...
Autores principales: | Supinski, Gerald S., Netzel, Paul F., Westgate, Philip M., Schroder, Elizabeth A., Wang, Lin, Callahan, Leigh Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390080/ https://www.ncbi.nlm.nih.gov/pubmed/34446067 http://dx.doi.org/10.1186/s13054-021-03737-9 |
Ejemplares similares
-
Does Standard Physical Therapy Increase Quadriceps Strength in Chronically Ventilated Patients? A Pilot Study
por: Supinski, Gerald S., et al.
Publicado: (2020) -
Eicosapentaenoic acid preserves diaphragm force generation following endotoxin administration
por: Supinski, Gerald S, et al.
Publicado: (2010) -
Diaphragm weakness and mechanical ventilation - what's the critical issue?
por: Callahan, Leigh Ann, et al.
Publicado: (2010) -
Diaphragm weakness in mechanically ventilated critically ill patients
por: Supinski, Gerald S, et al.
Publicado: (2013) -
Hyperglycemia-induced diaphragm weakness is mediated by oxidative stress
por: Callahan, Leigh A, et al.
Publicado: (2014)